Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Hires two, relocates custom library synthesis resources
June 20, 2012
By: Gil Roth
President, Pharma & Biopharma Outsourcing Association
AMRI has hired two experts in medicinal and computational chemistry at its research center located in Hyderabad, India (HRC). Simultaneously, the company has completed the relocation of its custom library synthesis resources and capabilities to HRC from its Budapest, Hungary operations. According to an AMRI statement, “The new hires and relocation of resources provide additional flexibility to enhance productivity and client service for AMRI’s global drug discovery operations, which draw upon a broad spectrum of service capabilities from multiple sites.” Srinivas Nanduri, Ph.D. was named director of medicinal chemistry in India, reporting to Subramanyam Maddala, president of India Operations. In addition, Suneel Kumar Bommisetty, Ph.D. was named senior research associate of computational chemistry, reporting to Dr. Nanduri. These newly created positions are intended to strengthen AMRI’s capabilities in problem-solving medicinal chemistry and complement its current strength in custom synthesis at HRC. “Dr. Nanduri and Dr. Bommisetty bring a high level of medicinal chemistry expertise, a strong track record of industry experience and additional drug discovery project management experience to the Hyderabad site,” Mr. Maddala said. “AMRI is committed to providing best-of-class services to our customers, and servicing the entire value chain of contract research services. These additions enhance our capabilities to move towards that target.” Dr. Nanduri most recently served as research director at Aurigene, where he was responsible for the execution and overall supervision of multiple integrated drug discovery projects, from hit generation through lead optimization. Prior to that, he was a chief scientific manager at Biocon-BMS Research Centre, where he led projects in the therapeutic areas of oncology, obesity and central nervous system disorders. Dr. Nanduri also had worked at Dr. Reddy’s, where he led multiple medicinal chemistry projects in oncology and metabolic disorders, as well as a number of natural products projects in the area of anti-cancer therapy. Dr. Bommisetty joins AMRI from GVK Biosciences and brings more than eight years of computational chemistry experience to HRC. He began his career as a research associate in 2004 while he obtained his Ph.D. in Computational Chemistry from JNTU. He played a dual role in GVK as a scientific associate and also as a senior faculty in GVK Bio campus, leading theory classes and lab sessions on molecular modeling, homology modeling, structure-based drug design and analog-based drug design.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !